May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Interleukin–1 Beta Type I Receptor (IL–1RI) Regulation in Retinal Endothelial Cells
Author Affiliations & Notes
  • C.A. Aveleira
    Center of Ophthalmology, IBILI –Faculty of Medicine, Coimbra, Portugal
  • N.F. Simoes
    Center of Ophthalmology, IBILI –Faculty of Medicine, Coimbra, Portugal
  • C.R. Fernandes
    Center of Ophthalmology, IBILI –Faculty of Medicine, Coimbra, Portugal
  • R.I. Meirinhos
    Center of Ophthalmology, IBILI –Faculty of Medicine, Coimbra, Portugal
  • E.C. Leal
    Center of Ophthalmology, IBILI –Faculty of Medicine, Coimbra, Portugal
  • K.–I. Hosoya
    Faculty Pharmaceutical Sciences, Toyama Medical Pharmaceutical University, Toyama, Japan
  • A.F. Ambrosio
    Center of Ophthalmology, IBILI –Faculty of Medicine, Coimbra, Portugal
  • Footnotes
    Commercial Relationships  C.A. Aveleira, None; N.F. Simoes, None; C.R. Fernandes, None; R.I. Meirinhos, None; E.C. Leal, None; K. Hosoya, None; A.F. Ambrosio, None.
  • Footnotes
    Support  FCT (POCTI/CBO/38545/2001; SFRH/BD/9686/2002; SFRH/BD/18827/2004) and FEDER
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 1728. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C.A. Aveleira, N.F. Simoes, C.R. Fernandes, R.I. Meirinhos, E.C. Leal, K.–I. Hosoya, A.F. Ambrosio; Interleukin–1 Beta Type I Receptor (IL–1RI) Regulation in Retinal Endothelial Cells . Invest. Ophthalmol. Vis. Sci. 2006;47(13):1728.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Diabetic Retinopathy has been considered a low–grade and chronic inflammatory disease. It was demonstrated that several genes involved in inflammatory processes are upregulated in diabetic retinas. The production of interleukin–1 beta (IL–1 beta), a pro–inflammatory cytokine, is increased, and it was correlated with an increase in blood–retinal barrier permeability. IL–1 beta elicits its pro–inflammatory action through the activation of IL–1 type I receptor (IL–1RI).The IL–1R accessory protein (IL–1RAcP) is a key element on the activation of the signal transduction cascade. We investigated the effect of high glucose and IL–1 beta on the IL–1RI and IL–1RAcP regulation, in retinal endothelial cells.

Methods: : Rat retinal capillary endothelial cells (TR–iBRB2 cell line) were exposed to high concentrations of glucose (30 mM) or mannitol (osmotic control), for 7 days. The cells were also exposed, in a time–dependent manner (1, 3, 6, 12 and 24h), to high glucose, mannitol or IL–1 beta (10 ng/ml). IL–1RI and IL–1RAcP immunoreactivity was evaluated by Western Blotting and immunocytochemistry.

Results: : Long–term exposure of retinal endothelial cells to high glucose or mannitol decreased the protein content of IL–1RI. A time–dependent downregulation of IL–1RI also occurred in cells exposed to high glucose, mannitol or IL–1 beta (1–24h). The protein content of IL–1RAcP did not change. The downregulation of IL–1RI induced by high glucose, mannitol or IL–1 beta was due to activation of IL–1RI by IL–1 beta, since it was prevented by the presence of antibodies against IL–1 beta or IL–1RI. The downregulation of IL–1RI induced by IL–1 beta was prevented by chloroquine (100 µM), a lysosome inhibitor, but not by MG132 (40 µM), a proteasome inhibitor.

Conclusions: : Retinal endothelial cells express IL–1RI and IL–1RAcP, and, therefore can be affected by IL–1 beta. Our results indicate that high glucose, probably due to osmotic stress, and IL–1 beta downregulate the protein expression of IL–1RI in retinal endothelial cells. The downregulation of IL–1RI is triggered by its activation and it is due, at least partially, to lysosomal degradation.

Keywords: diabetic retinopathy • inflammation • signal transduction 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×